3KJB.F 0.98 (-3.92%)
CA05475P1099Drug ManufacturersDrug Manufacturers - Specialty & Generic

Ayr Wellness (3KJB.F) Competitor Comparison

We are evaluating the key criteria listed to compare Ayr Wellness (3KJB.F) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 3 years - 3KJB.F ranking 49 / 54

These are the competitors of Ayr Wellness in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 3 years
1. Kamada KMDA
524.51
2. Phibro Animal Health PAHC
39.25
3. Supernus Pharmaceuticals SUPN
34.98
4. Kolinpharma KIP.MI
11.59
5. Zoetis ZTS
11.3
6. ANI Pharmaceuticals ANIP
10.8
7. Alimera Sciences ALIM
8.97
8. Vifor Pharma G2AB.F
6.24
9. Alvotech ALVO
5.47
10. PetIQ PETQ
5.03
11. ProPhase Labs PRPH
4.77
12. Perrigo PRGO
4.39
13. Regencell Bioscience Holdings RGC
4.34
14. Taro Pharmaceutical Industries TARO
3.87
15. Green Thumb Industries R9U2.F
3.81
16. Cumberland Pharmaceuticals CPIX
3.76
17. Avadel Pharmaceuticals AVDL
3.6
18. Ironwood Pharmaceuticals IRWD
3.33
19. Catalent CTLT
3.18
20. Journey Medical DERM
3.02
21. Pacira BioSciences PCRX
3.02
22. Zynerba Pharmaceuticals ZYNE
3
23. Linc LNC
2.98
24. Cronos Group CRON
2.67
25. Embecta EMBC
2.55
26. OptiNose OPTN
2.55
27. Collegium Pharmaceutical COLL
2.52
28. Elanco Animal Health ELAN
2.52
29. Societal CDMO SCTL
2.41
30. Curaleaf Holdings CURLF
2.4
31. Emergent BioSolutions EBS
2.37
32. Procaps Group PROC
2.28
33. SCYNEXIS SCYX
2.23
34. Bausch Health Companies BHC
2.17
35. Organogenesis Holdings ORGO
1.97
36. Eagle Pharmaceuticals EGRX
1.94
37. Relmada Therapeutics RLMD
1.86
38. Jupiter Wellness JUPW
1.84
39. Theratechnologies THTX
1.8
40. Alpha Teknova TKNO
1.77
41. Ascend Wellness Holdings AAWH
1.76
42. Flora Growth FLGC
1.74
43. Universe Pharmaceuticals UPC
1.74
44. Tilray Brands TLRY
1.73
45. Biofrontera BFRI
1.68
46. Solid Biosciences SLDB
1.63
47. Amphastar Pharmaceuticals AMPH
1.62
48. Amneal Pharmaceuticals AMRX
1.59
49. Ayr Wellness 3KJB.F
1.58
50. Neoleukin Therapeutics NLTX
1.57
51. Clever Leaves Holdings CLVR
1.47
52. Teva Pharmaceutical Industries TEVA
1.32
53. Evolus EOLS
1.26
54. Harrow Health HROW
0.39

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.